###begin article-title 0
The +299(G>A) Resistin Gene Polymorphism and Susceptibility to Type 2 Diabetes in Thais
###end article-title 0
###begin p 1
###xml 927 928 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1031 1032 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1163 1164 1163 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 859 867 <span type="species:ncbi:9606">patients</span>
The prevalence of type 2 diabetes has been increased in Thais. Resistin is an adipokine that involve in glucose homeostasis and is a candidate gene for type 2 diabetes. We performed a case-control study in representative sample of 200 Thai volunteers, 105 controls and 95 type 2 diabetes subjects. The purposes of the present study were to investigate the association between two SNPs (single nucleotide polymorphisms) in the resistin gene, at positions +299(G>A) and -420(C>G), and biochemical parameters; to determine whether these polymorphisms are linked to increased risk of type 2 diabetes. At position +299(G>A) of the resistin gene, the resistin concentration among type 2 diabetes subjects was significantly higher in GA/AA genotypes (3.40 ng/ml) than the GG genotype (1.99 ng/ml). Resistin gene polymorphism at position +299(G>A) in type 2 diabetes patients was significantly more frequent than in the control group (p = 0.004). Polymorphism at position -420(C>G) showed no significant relationship with type 2 diabetes (p = 0.095). Logistic regression analysis was shown that +299(G>A) gene polymorphism was increased risk factors for type 2 diabetes (p = 0.013). In conclusion, these finding suggest that resistin gene polymorphism at position +299(G>A) has impact on the increased resistin concentrations and may influence susceptibility to type 2 diabetes in Thais.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 603 604 603 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 849 850 849 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 852 853 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 937 938 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1188 1190 1188 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1256 1257 1256 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1393 1395 1393 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1478 1480 1478 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 705 713 <span type="species:ncbi:9606">patients</span>
###xml 1658 1664 <span type="species:ncbi:9606">humans</span>
The type 2 diabetes is increasing rapidly, and is becoming a significant global health problem. White adipose tissue secretes a variety of adipokines, which may provide the link between insulin resistance and obesity, and resistin is one such molecule [1, 2]. The human resistin gene is localized to chromosome 19p13.3. Resistin suppressed adipocyte differentiation by 80% in 3T3-L1 cells [3]; failure of adipocyte differentiation has been suggested as a cause of type 2 diabetes, possibly through an ectopic overload of fatty acids and lipotoxicity of nonadipose tissues, such as muscles and liver [4, 5]. The function of resistin related to glucose homeostasis and insulin resistance in type 2 diabetes patients, is not consistent. Some studies have reported increased resistin expression levels in type 2 diabetes, insulin resistance or obesity [6, 7], whereas some failed to detect any change in resistin levels in these conditions [8-10]. The results of studies investigating genetic variations in resistin, including single nucleotide polymorphisms (SNPs), are controversial. The SNP on the resistin gene promoter -420(C>G) has been associated with a prevalence of type 2 diabetes [11], but not all reports have consistently produced these findings [1]. Genetic variant at nucleotide +299 (IVS2 +181(G>A) and obesity have been reported as risk factors for type 2 diabetes in Caucasians [12]. However, the findings for a Japanese type 2 diabetes population did not concur [13]. Overall, some, but not all, studies have found associations between resistin gene polymorphism, and type 2 diabetes. Therefore, the genetic variations of the resistin gene in humans require clarification. The purposes of the present study were to investigate the association between two SNPs in the resistin gene, one promoter variant at position -420(C>G) and one intron 2 variants at position +299(G>A) from a translation start site, and the levels of resistin, glucose, insulin, total cholesterol, triglycerides, blood urea nitrogen, creatinine, blood pressure, and anthropometric variables; to determine whether these polymorphisms are linked to increased risk of type 2 diabetes.
###end p 3
###begin title 4
Materials and Methods
###end title 4
###begin title 5
Study population
###end title 5
###begin p 6
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 175 183 <span type="species:ncbi:9606">patients</span>
###xml 821 833 <span type="species:ncbi:9606">participants</span>
The case-control study comprised of 200 subjects allocated into 2 groups. The first group was controls without type 2 diabetes (n = 105); the second group was type 2 diabetes patients (n = 95). Diabetes was diagnosed based on the American Diabetes Association criteria, reported in 2008 [14]. Subjects were excluded if they had severe hypertension, liver, kidney, thyroid, cardiovascular or any active inflammatory diseases, as well as receiving insulin. The same medical doctor conducted the physical examinations throughout the study and measured blood pressure (BP). The type 2 diabetes subjects were volunteers from a diabetes mellitus outpatient clinic of Burapha University Hospital, Chonburi and Rajvithi Hospital, Bangkok, Thailand. The protocol was approved by the Ethics Committee of Burapha University and all participants agreeing to participate by signing informed consent form.
###end p 6
###begin title 7
Biological measurements
###end title 7
###begin p 8
###xml 273 274 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The body weight of each subjects was measured using a carefully calibrated beam balance (Detecto(R), Detecto Scale Manufacturing, MO). Height was measured using a vertical measuring rod. Body Mass Index (BMI) was conventionally calculated as weight in kg/(height in meters)2. Waist and hip circumferences were assessed and Waist and hip ratio (WHR) was calculated.
###end p 8
###begin p 9
About 10 ml of venous blood were taken from the subjects in the morning, after overnight fast. Resistin concentrations were determined by sandwich enzyme-linked immunosorbent assay (sandwich ELISA) and insulin concentrations by radioimmunoassay (Linco Research, Inc., MO.). Glucose, blood urea nitrogen (BUN), creatinine, total cholesterol (TC), and triglycerides (TG) were measured using enzymatic methods by DADE Dimension (R)AR.
###end p 9
###begin title 10
Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique
###end title 10
###begin p 11
###xml 381 387 381 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 491 496 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bpi I</italic>
###xml 520 525 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu I</italic>
DNA was extracted from EDTA-treated whole blood by Flexi Gene DNA kit (QIAGEN, Hilden, Germany). DNA-fragments of the SNPs -420 and +299 were amplified by PCR (PE Applied Biosystems) with the following primers-(5'-3'): SNP -420 forward TGTCATTCTCACCCAGAGACA, reverse TGGGCTCAGCTAACCAAATC, SNP + 299 forward GAGAGGATCCAGGAGGTC, reverse GTGAGACCAAACGGTCCCTG, as described by Kunnari et al. [15]. The PCR products were digested overnight with different restriction enzymes. For SNP-420, 5 U of Bpi I, and for SNP + 299 the Alu I restriction endonuclease, were used. The digestion products were separated by 2% agarose gels stained with ethidium bromide.
###end p 11
###begin title 12
Statistical analysis
###end title 12
###begin p 13
###xml 566 567 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical analyses were carried out using SPSS for Windows version 11.5 (SPSS, Chicago, IL). The median, range and 95% confidence interval (C.I.) were calculated. The difference between groups was compared by using the Mann-Whitney U-Wilcoxon Rank Sum W test. The difference in genotypic frequencies of the two groups was assessed by Chi-square test. The Minitab statistical computer program was used to calculate the odds ratio (OR). To assess the associated between type 2 diabetes as dependent variable and potential factors, logistic regression was applied. A p value<0.05 was considered statistically significant.
###end p 13
###begin title 14
Results
###end title 14
###begin p 15
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 497 498 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 1063 1064 1063 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1424 1425 1424 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 1605 1606 1605 1606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1709 1710 1709 1710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1936 1937 1936 1937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 1971 1972 1971 1972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2010 2011 2010 2011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2077 2078 2077 2078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2141 2142 2141 2142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 2369 2370 2369 2370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The median and 95% confidence interval (C.I.) for age, anthropometric variables, blood pressure, glucose, BUN, creatinine, total cholesterol, triglycerides, insulin, and resistin levels were shown in Table 1. Age, BMI, BUN and blood pressure of type 2 diabetes group were not statistically significantly different from those of control group. The medians of waist/hip ratio, glucose, insulin, resistin, creatinine and lipids were significantly higher in the type 2 diabetes than control subjects (p<0.050). The anthropometric variables, blood pressure, and biochemical parameters of the type 2 diabetes subjects, for resistin polymorphism genotypes at positions +299 and -420, were shown in Table 2. With regard to +299(G>A) polymorphism in type 2 diabetes subjects, there were no differences in anthropometric variables, blood pressure or biochemical parameters between the different genotypes, except for resistin. Resistin concentrations were higher in the GA/AA genotypes, heterozygous combined with homozygous mutant types, than the GG genotype (wild type) (p<0.050). Regarding to the -420(C>G) polymorphism in type 2 diabetes subjects, the data revealed no significant differences in any variable between the CG/GG genotypes (heterozygous combined with homozygous mutant types) and the CC genotype (wild type). The frequency of resistin gene polymorphism at +299(G>A) and -420(C>G) in all subjects were shown in Table 3. At +299(G>A) polymorphism, 31% of GA/AA genotype had type 2 diabetes, and resistin gene polymorphism at this position were significantly more frequent than in the control group (p = 0.004). Polymorphism at position -420(C>G) showed no significant relationship with type 2 diabetes (p = 0.095). Logistic regression and odds ratios (OR) for possible associations between type 2 diabetes and age, waist/hip ratio and two resistin gene polymorphism at positions +299(G>A) as well as -420(C>G) were shown in Table 4. Three variables, age (OR = 1.1, p = 0.014), waist/hip ratio (OR = 3.5, p = 0.020) and gene polymorphism at positions +299(G>A) (OR = 2.3, p = 0.013), showed statistically significant association. Table 5 showed the relationship between hyperglycemia at cut off point > 126 mg/dl and gene polymorphisms. There was a statistically significant association between hyperglycemia and resistin gene polymorphism at positions +299(G>A) (p<0.05), except for the position -420(C>G).
###end p 15
###begin title 16
Discussion
###end title 16
###begin p 17
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 751 752 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1182 1184 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1311 1312 1311 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1314 1316 1314 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 199 203 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
###xml 601 609 <span type="species:ncbi:9606">patients</span>
###xml 1118 1126 <span type="species:ncbi:9606">patients</span>
###xml 1301 1309 <span type="species:ncbi:9606">patients</span>
Many studies tried to elucidate the functions of resistin, and reported that resistin may impair glucose tolerance, insulin action, and decreased glucose uptake in skeletal muscle cells [16, 17]. In mice, neutralizing resistin with antibody improved insulin action and glucose uptake in diet-induced obesity [2]. Resistin was four times more highly expressed in human omental and abdominal subcutaneous white adipocytes than in adipocytes from the thigh, suggesting that human resistin could play a major role in obesity-related insulin resistance [18]. It was well known that most of type 2 diabetic patients were related to obesity and insulin resistance. Some authors reported that serum resistin levels were increased in type 2 diabetes subjects [7, 19]. Such findings have been re-confirmed by this study. Likewise, in Thai subjects, the type 2 diabetes group had higher waist/hip ratio and resistin levels than the control group so it could be indicated that type 2 diabetes mellitus was associated with increased central obesity. In contrast, other studies found no difference in plasma resistin levels between patients with type 1 and type 2 diabetes, and healthy controls [20]. Studies have reported no association between resistin levels and markers of insulin resistance in type 2 diabetes patients [8, 21]. Therefore, the true function of resistin requires further study.
###end p 17
###begin p 18
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 790 796 790 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 908 909 908 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1029 1031 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1202 1208 1202 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1210 1212 1210 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1339 1341 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1437 1439 1437 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1689 1691 1689 1691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1717 1723 1717 1723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 1834 1836 1834 1836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 2709 2715 2709 2715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 3010 3012 3006 3008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 3174 3176 3170 3172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 3252 3269 3248 3265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gymnema sylvestre</italic>
###xml 3416 3418 3412 3414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 3252 3269 <span type="species:ncbi:4068">Gymnema sylvestre</span>
The human resistin gene is localized on chromosome 19. Results of studies investigating genetic variations in the resistin gene were controversial. Our observations found an association between resistin gene polymorphism at +299(G>A) in type 2 diabetes and higher resistin concentration, but not in subjects carrying CG/GG resistin gene genotypes at -420(C>G). In a Japanese population, the -420 GG genotype was associated with type 2 diabetes; the -420 GG resistin genotype was related to increased promoter activity through specific Sp1/3 binding, which in turn, leads to increased resistin levels and increased risk of type 2 diabetes [11]. However, the current study found that polymorphism at -420(G>C) was not significantly associated with increased risk of type 2 diabetes. Conneely et al. failed to detect any correlation between resistin gene promoter polymorphism at -420(G>C) and type 2 diabetes [1]. No association between SNP of the resistin gene in the promoter region with obesity or insulin resistance was found [22]. Our study did not find a significantly increased risk of type 2 diabetes in resistin gene polymorphism at position -420 (C>G), and similar data were reported by Engert et al. [23]. In Caucasians, a resistin genotype at position +299(G>A) and obesity was a significant determinant of type 2 diabetes risk [12] whereas resistin gene +299(G>A) was not associated with type 2 diabetes in Japanese subjects [13]. This polymorphism is in an intron, +299(G>A), which generally has not been considered to have regulatory functions. However, it has been shown that SNPs in the noncoding region, such as the 3'-untranslated gene region, can affect gene expression [24]. Intron polymorphism of TFAP2B, a susceptibility gene to type 2 diabetes, influenced adipocytokine gene expression transcriptional activity [25]. Therefore, resistin gene polymorphism at +299(G>A) may be a marker in linkage disequilibrium with an other polymorphism affecting gene expression. Resistin gene polymorphism at +299(G>A) in Thai diabetic subjects may contribute to increased resistin levels, which may be involved in the pathogenesis of type 2 diabetes by impaired insulin action. Logistic regression analysis of this study showed that +299(G>A) polymorphism, age and waist/hip ratio were linked to significantly increased risk of type 2 diabetes in Thais. The inconsistencies of resistin gene polymorphism among studies might be explained by the different genetic backgrounds or environmental conditions of the population studied. Furthermore, our study showed that there was a statistically significant association between hyperglycemia and resistin gene polymorphism at positions +299(G>A). Kiritoshi et al., showed that hyperglycemia increased reactive oxygen species produced by mitochondria, resulting in activation of nuclear factor kappaB, induction of cyclooxygenase-2 gene expression. These results might contribute to the pathogenesis of diabetic complications especially diabetic nephropathy [26]. Astaxanthin was a carotenoid that might scavenge the production of reactive oxygen species in mitochondria and has protective effects on diabetic nephropathy [27]. Therefore, type 2 diabetes should control the level of blood glucose and Gymnema sylvestre was one of alternative herbal medicines that might help to treat diabetes mellitus by preventing the sugar molecules absorption in the intestine [28].
###end p 18
###begin p 19
In summary, we found that type 2 diabetic subjects displayed a significantly increased resistin concentration than controls and the levels of resistin in type 2 diabetes with GA/AA genotypes were significantly higher than those with the GG genotype. The resistin gene polymorphism at +299(G>A) appeared to affect susceptibility to type 2 diabetes, especially among Thais, whereas -420(C>G) polymorphism was unlikely to play a major function in the etiology of type 2 diabetes among the Thai population. Moreover, we found that waist/hip ratio and age were also significantly associated with increased risk of type 2 diabetes. Further studies are needed to fully clarify the role of the resistin gene in type 2 diabetes, by investigation of other populations including large population-sample sizes, and how resistin polymorphism at +299(G>A) affects gene expression.
###end p 19
###begin title 20
Acknowledgements
###end title 20
###begin p 21
###xml 311 318 <span type="species:ncbi:9606">patient</span>
The authors wish to express their sincere thanks to all volunteers, staff of the Department of Tropical Nutrition and Food Science, Faculty of Tropical Medicine, Mahidol University. Mr. Paul Adams for reading the manuscript, and all staff of the Diabetes Outpatient Clinic, Burapha University Hospital, and Out-patient General Practice Section, Rajvithi Hospital for their cooperation in this research. This work was partially supported by funds from Mahidol University and the Rangsit University Research Fund, Thailand.
###end p 21
###begin title 22
Abbreviations
###end title 22
###begin p 23
single nucleotide polymorphisms
###end p 23
###begin p 24
blood pressures
###end p 24
###begin p 25
Body Mass Index
###end p 25
###begin p 26
Waist and hip ratio
###end p 26
###begin p 27
blood urea nitrogen
###end p 27
###begin p 28
total cholesterol
###end p 28
###begin p 29
triglycerides
###end p 29
###begin title 30
References
###end title 30
###begin article-title 31
Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects
###end article-title 31
###begin article-title 32
The hormone resistin links obesity to diabetes
###end article-title 32
###begin article-title 33
A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation
###end article-title 33
###begin article-title 34
Failure of adipocyte differentiation causes type II diabetes mellitus?
###end article-title 34
###begin article-title 35
Dysregulation of fatty acid metabolism in the etiology of type-2 diabetes
###end article-title 35
###begin article-title 36
###xml 53 59 <span type="species:ncbi:9606">humans</span>
Serum resistin (FIZZ3) protein is increased in obese humans
###end article-title 36
###begin article-title 37
###xml 168 173 <span type="species:ncbi:9606">human</span>
Resistin and type-2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes
###end article-title 37
###begin article-title 38
###xml 85 91 <span type="species:ncbi:9606">humans</span>
Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: crosssectional and interventional studies in normal, insulin-resistant, and diabetic subjects
###end article-title 38
###begin article-title 39
###xml 81 87 <span type="species:ncbi:9606">humans</span>
Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans
###end article-title 39
###begin article-title 40
###xml 40 48 <span type="species:ncbi:9606">children</span>
Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance
###end article-title 40
###begin article-title 41
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type-2 diabetes mellitus susceptibility by inducing p2004; romoter activity through specific binding of Sp1/3
###end article-title 41
###begin article-title 42
Genetic variants at the resistin locus and risk of type-2 diabetes in Caucasians
###end article-title 42
###begin article-title 43
The absence of evidence for major effects of the frequent SNP +299G>A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type-2 diabetes
###end article-title 43
###begin article-title 44
Diagnosis and classification of diabetes mellitus
###end article-title 44
###begin article-title 45
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients
###end article-title 45
###begin article-title 46
Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production
###end article-title 46
###begin article-title 47
Regulation of adipocytokines and insulin resistance
###end article-title 47
###begin article-title 48
Resistin, central obesity, and type-2 diabetes
###end article-title 48
###begin article-title 49
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type-2 diabetes
###end article-title 49
###begin article-title 50
###xml 26 34 <span type="species:ncbi:9606">patients</span>
Plasma resistin levels in patients with Type 1 and Type-2 diabetes mellitus and in healthy controls
###end article-title 50
###begin article-title 51
###xml 27 34 <span type="species:ncbi:9606">persons</span>
Resistin concentrations in persons with type-2 diabetes mellitus and in individuals with acute inflammatory disease
###end article-title 51
###begin article-title 52
Variation in resistin gene promoter not associated with polycystic ovary syndrome
###end article-title 52
###begin article-title 53
5' flanking variants of resistin are associated with obesity
###end article-title 53
###begin article-title 54
Structural and functional features of eukaryotic mRNA untranslated regions
###end article-title 54
###begin article-title 55
Intronic polymorphisms within TFAP2B regulate transcriptional activity and affect adipocytokine gene expression in differentiated adipocytes
###end article-title 55
###begin article-title 56
###xml 85 90 <span type="species:ncbi:9606">human</span>
Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy
###end article-title 56
###begin article-title 57
Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling
###end article-title 57
###begin article-title 58
###xml 0 17 <span type="species:ncbi:4068">Gymnema sylvestre</span>
Gymnema sylvestre: A Memoir
###end article-title 58
###begin p 59
Median and 95% confidence interval (C.I.) for age, anthropometric variables, blood pressure, and biochemical parameters in control and type 2 diabetes
###end p 59
###begin p 60
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p<0.05 by using Mann-Whitney U-Wilcoxon Rank Sum W test (Two-Tailed).
###end p 60
###begin p 61
C.I., Confidence Interval.
###end p 61
###begin p 62
Median and 95% confidence interval (C.I.) for age, anthropometric variables, blood pressure, and biochemical parameters in type 2 diabetes.
###end p 62
###begin p 63
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p<0.05 by Mann-Whitney U-Wilcoxon Rank Sum W test (two-tailed).
###end p 63
###begin p 64
C.I., Confidence Interval.
###end p 64
###begin p 65
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Genotype frequencies of +299(G>A) and -420(C>G) polymorphisms in all subjects (n = 200)
###end p 65
###begin p 66
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 23 24 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
a Pearson chi-square, *p<0.05
###end p 66
###begin p 67
Logistic regression analysis when type 2 diabetes was used as dependent variable and age, waist/hip ratio and resistin gene polymorphism at +299(G>A) as well as at -420(C>G) were taken as independent variables.
###end p 67
###begin p 68
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p<0.05
###end p 68
###begin p 69
C.I., Confidence Interval
###end p 69
###begin p 70
The relationship between hyperglycemia and gene polymorphisms when hyperglycemia (cut off point>126 mg/dl) was used as dependent variable.
###end p 70
###begin p 71
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p<0.05
###end p 71

